| Authors: |
DaSilva B; Department of Medicine, Stanford University School of Medicine, Stanford, CA.; Division of Hematology Oncology, Department of Medicine, Columbia University, New York, NY., Darwin A; Department of Medicine, Stanford University School of Medicine, Stanford, CA., Zhang A; Quantitative Sciences Unit, Stanford University School of Medicine, Stanford, CA., Vyas RD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Russell K; Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA., Gilbert JS; Department of Medicine, University of Colorado School of Medicine, Aurora, CO., Tan V; Department of Medicine, Oregon Health & Science University, Portland, OR., Feldt S; Department of Medicine, The University of Chicago, Chicago, IL., Johnston H; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL., Liang EC; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., DuVall AS; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL., Liedtke M; Division of Hematology, Stanford Cancer Center, Palo Alto, CA., Stock W; Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL., Cassaday RD; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.; Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, WA., Schwartz M; Division of Hematology, University of Colorado, Aurora, CO., Leonard JT; Department of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR., Muffly LS; Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Stanford, CA., Luskin MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. |
